Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 3
1(16.7%)
6Total
N/A(5)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07477041Not ApplicableCompleted

Promotion of Breast Milk Donation in Breastfeeding Mothers Through a Mobile Health Intervention Using Amamantapp

Role: lead

NCT06777407Not ApplicableActive Not Recruiting

Brief Mindfulness-Based Intervention to Reduce Psychological Distress in Health Sciences Students

Role: lead

NCT06502327Not ApplicableCompleted

Comparison of Visual Instructions for Inserting a Laryngeal Mask in a Neonatal Mannequin.

Role: lead

NCT04612972Phase 3Completed

Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru

Role: collaborator

NCT04945382Not ApplicableUnknown

Retention of a Flowable Resin-based Sealant With Two Types of Adhesives

Role: lead

NCT01296958Not ApplicableCompleted

Targeted Screening for Taenia Solium Tapeworms

Role: collaborator

All 6 trials loaded